5195.0000 -49.00 (-0.93%)
NSE May 16, 2025 15:31 PM
Volume: 5,034
 

5195.00
-0.93%
IDBI Capital
EBITDA margin of 18.1% were higher than our estimates of 11.5%. Similarly, PAT of Rs317mn, +11.2% YoY, was higher than our estimates. We maintain our CY17E/18E estimates and TP (Rs1,179, 17x CY18E EPS+ CCE of Rs267/sh) and our rating of HOLD. Key Highlights and Investment Rationale India and other regions to fill the gap All players have seen the reversal patterns with the re-stocking happening in the channels which had got impacted during the last quarter due to the implementation...
Procter & Gamble Health Ltd. is trading above its 50 day SMA of 5184.0
More from Procter & Gamble Health Ltd.
Recommended